AD/HD Diagnosis Rate, Stimulant Medication Use Have Leveled Off Since Implementation Of New Treatment Guidelines, Researchers Say

HealthDay (11/15, Reinberg) reported that “the rate of diagnoses for attention-deficit/hyperactivity disorder” (AD/HD) “among US preschoolers has leveled off,” and the “prescribing rate of stimulant medications for these young patients has also stayed steady, a promising trend that researchers credit to treatment guidelines that were introduced” five years ago by the American Academy of Pediatrics. Those guidelines “called for a standardized approach to diagnosis, and recommended behavior therapy,” not medications, “as the first-line therapy for preschoolers.”

Medscape (11/15, Phillips) reports some “21, 558 visits from 143,881 children at 63 primary care practices” were included in the study, the findings of which were published online Nov. 15 in Pediatrics. The author of an accompanying editorialobserved, “This approach ‘is an innovative process that can provide more rigorous information about moving evidence into practice.’

Related Links:

— “Guidelines May Have Helped Curb ADHD Diagnoses in Preschoolers,” Steven Reinberg, HealthDay, November 15, 2016.

Posted in In The News.